25 XP   0   0   10

Zhejiang Chimin Pharm Co Ltd
Buy, Hold or Sell?

Let's analyse Chimin together

PenkeI guess you are interested in Zhejiang Chimin Pharm Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Chimin Pharm Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Chimin Pharm Co Ltd

I send you an email if I find something interesting about Zhejiang Chimin Pharm Co Ltd.

Quick analysis of Chimin (30 sec.)










What can you expect buying and holding a share of Chimin? (30 sec.)

How much money do you get?

How much money do you get?
¥0.06
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.30
Expected worth in 1 year
¥6.28
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥3.42
Return On Investment
61.3%

For what price can you sell your share?

Current Price per Share
¥5.59
Expected price per share
¥4.7 - ¥6.24
How sure are you?
50%

1. Valuation of Chimin (5 min.)




Live pricePrice per Share (EOD)

¥5.59

Intrinsic Value Per Share

¥-1.32 - ¥4.62

Total Value Per Share

¥1.98 - ¥7.92

2. Growth of Chimin (5 min.)




Is Chimin growing?

Current yearPrevious yearGrowGrow %
How rich?$245.2m$189.9m$55.2m22.5%

How much money is Chimin making?

Current yearPrevious yearGrowGrow %
Making money$4.7m$20.3m-$15.6m-328.0%
Net Profit Margin4.1%13.4%--

How much money comes from the company's main activities?

3. Financial Health of Chimin (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#78 / 171

Most Revenue
#75 / 171

Most Profit
#79 / 171

What can you expect buying and holding a share of Chimin? (5 min.)

Welcome investor! Chimin's management wants to use your money to grow the business. In return you get a share of Chimin.

What can you expect buying and holding a share of Chimin?

First you should know what it really means to hold a share of Chimin. And how you can make/lose money.

Speculation

The Price per Share of Chimin is ¥5.59. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Chimin.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Chimin, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.30. Based on the TTM, the Book Value Change Per Share is ¥0.74 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.61 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.11 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Chimin.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.2%0.010.2%0.040.7%0.010.3%0.010.3%
Usd Book Value Change Per Share0.101.8%0.101.8%0.081.5%0.040.8%0.030.6%
Usd Dividend Per Share0.020.3%0.020.3%0.010.2%0.010.2%0.010.2%
Usd Total Gains Per Share0.122.1%0.122.1%0.091.7%0.061.0%0.040.8%
Usd Price Per Share1.21-1.21-2.54-3.02-2.51-
Price to Earnings Ratio136.38-136.38-67.01-398.67-279.03-
Price-to-Total Gains Ratio10.22-10.22-26.99-135.09-118.02-
Price to Book Ratio2.65-2.65-7.19-10.26-9.99-
Price-to-Total Gains Ratio10.22-10.22-26.99-135.09-118.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.772538
Number of shares1294
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share0.100.04
Usd Total Gains Per Share0.120.06
Gains per Quarter (1294 shares)153.0973.33
Gains per Year (1294 shares)612.36293.31
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
18053260268225283
216010651214136451576
324015971826204676869
4320213024382729011162
54002662305034011271455
64803194366240813521748
75603727427447615772041
86404259488654418032334
97204792549861220282627
108005324611068022532920

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%10.02.00.083.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%11.01.00.091.7%

Fundamentals of Chimin

About Zhejiang Chimin Pharm Co Ltd

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells human medicines and medical devices in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, including safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products. In addition, the company provides in vitro diagnostics products, such as clinical chemical diagnostic, immunological diagnostic, blood testing, rapid diagnostic, and enzyme-linked immunological diagnostic reagents; laboratory instruments; and in vitro diagnostic medical products, as well as FOB fecal occult blood automatic immune monitoring and pylori Helicobacter detection kits. Further, it offers hemodialysis series products, including hemodialysis concentrate, hemodialysis tubing, and other products; and medical and health services. The company was formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd. and changed its name to Chimin Health Management Co., Ltd. in August 2018. Chimin Health Management Co., Ltd. was founded in 1996 and is based in Taizhou, China.

Fundamental data was last updated by Penke on 2024-04-18 11:48:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Zhejiang Chimin Pharm Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Chimin earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Chimin to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 4.1% means that ¥0.04 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Chimin Pharm Co Ltd:

  • The MRQ is 4.1%. The company is making a profit. +1
  • The TTM is 4.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.1%TTM4.1%0.0%
TTM4.1%YOY13.4%-9.3%
TTM4.1%5Y6.4%-2.3%
5Y6.4%10Y8.8%-2.4%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1%6.3%-2.2%
TTM4.1%6.5%-2.4%
YOY13.4%8.2%+5.2%
5Y6.4%7.3%-0.9%
10Y8.8%7.6%+1.2%
1.1.2. Return on Assets

Shows how efficient Chimin is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Chimin to the Medical Instruments & Supplies industry mean.
  • 1.3% Return on Assets means that Chimin generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Chimin Pharm Co Ltd:

  • The MRQ is 1.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.3%TTM1.3%0.0%
TTM1.3%YOY6.1%-4.8%
TTM1.3%5Y2.5%-1.2%
5Y2.5%10Y4.7%-2.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3%1.3%0.0%
TTM1.3%1.4%-0.1%
YOY6.1%2.0%+4.1%
5Y2.5%2.2%+0.3%
10Y4.7%2.0%+2.7%
1.1.3. Return on Equity

Shows how efficient Chimin is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Chimin to the Medical Instruments & Supplies industry mean.
  • 2.0% Return on Equity means Chimin generated ¥0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Chimin Pharm Co Ltd:

  • The MRQ is 2.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.0%TTM2.0%0.0%
TTM2.0%YOY11.9%-9.9%
TTM2.0%5Y5.3%-3.3%
5Y5.3%10Y7.6%-2.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0%2.6%-0.6%
TTM2.0%2.9%-0.9%
YOY11.9%3.9%+8.0%
5Y5.3%3.9%+1.4%
10Y7.6%4.0%+3.6%

1.2. Operating Efficiency of Zhejiang Chimin Pharm Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Chimin is operating .

  • Measures how much profit Chimin makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Chimin to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 10.3% means the company generated ¥0.10  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Chimin Pharm Co Ltd:

  • The MRQ is 10.3%. The company is operating less efficient.
  • The TTM is 10.3%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ10.3%TTM10.3%0.0%
TTM10.3%YOY19.0%-8.7%
TTM10.3%5Y12.5%-2.2%
5Y12.5%10Y10.6%+1.9%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ10.3%7.9%+2.4%
TTM10.3%7.6%+2.7%
YOY19.0%11.4%+7.6%
5Y12.5%10.2%+2.3%
10Y10.6%10.7%-0.1%
1.2.2. Operating Ratio

Measures how efficient Chimin is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.40 means that the operating costs are ¥1.40 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Chimin Pharm Co Ltd:

  • The MRQ is 1.405. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.405. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.405TTM1.4050.000
TTM1.405YOY1.315+0.090
TTM1.4055Y1.412-0.008
5Y1.41210Y1.222+0.190
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4051.133+0.272
TTM1.4051.124+0.281
YOY1.3151.082+0.233
5Y1.4121.101+0.311
10Y1.2221.056+0.166

1.3. Liquidity of Zhejiang Chimin Pharm Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Chimin is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.79 means the company has ¥1.79 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Chimin Pharm Co Ltd:

  • The MRQ is 1.792. The company is able to pay all its short-term debts. +1
  • The TTM is 1.792. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.792TTM1.7920.000
TTM1.792YOY1.122+0.670
TTM1.7925Y1.136+0.656
5Y1.13610Y1.816-0.680
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7922.320-0.528
TTM1.7922.382-0.590
YOY1.1222.575-1.453
5Y1.1362.627-1.491
10Y1.8162.623-0.807
1.3.2. Quick Ratio

Measures if Chimin is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Chimin to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.25 means the company can pay off ¥0.25 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Chimin Pharm Co Ltd:

  • The MRQ is 0.247. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.247. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.247TTM0.2470.000
TTM0.247YOY0.336-0.089
TTM0.2475Y0.401-0.154
5Y0.40110Y0.751-0.350
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2471.111-0.864
TTM0.2471.137-0.890
YOY0.3361.286-0.950
5Y0.4011.423-1.022
10Y0.7511.521-0.770

1.4. Solvency of Zhejiang Chimin Pharm Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Chimin assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Chimin to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.35 means that Chimin assets are financed with 34.6% credit (debt) and the remaining percentage (100% - 34.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Chimin Pharm Co Ltd:

  • The MRQ is 0.346. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.346. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.346TTM0.3460.000
TTM0.346YOY0.433-0.087
TTM0.3465Y0.463-0.117
5Y0.46310Y0.357+0.106
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3460.351-0.005
TTM0.3460.357-0.011
YOY0.4330.357+0.076
5Y0.4630.359+0.104
10Y0.3570.371-0.014
1.4.2. Debt to Equity Ratio

Measures if Chimin is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Chimin to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 55.0% means that company has ¥0.55 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Chimin Pharm Co Ltd:

  • The MRQ is 0.550. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.550. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.550TTM0.5500.000
TTM0.550YOY0.848-0.298
TTM0.5505Y1.066-0.516
5Y1.06610Y0.731+0.335
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5500.541+0.009
TTM0.5500.559-0.009
YOY0.8480.545+0.303
5Y1.0660.610+0.456
10Y0.7310.669+0.062

2. Market Valuation of Zhejiang Chimin Pharm Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Chimin generates.

  • Above 15 is considered overpriced but always compare Chimin to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 136.38 means the investor is paying ¥136.38 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Chimin Pharm Co Ltd:

  • The EOD is 87.126. Based on the earnings, the company is expensive. -2
  • The MRQ is 136.378. Based on the earnings, the company is expensive. -2
  • The TTM is 136.378. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD87.126MRQ136.378-49.252
MRQ136.378TTM136.3780.000
TTM136.378YOY67.009+69.370
TTM136.3785Y398.668-262.289
5Y398.66810Y279.030+119.637
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD87.12614.638+72.488
MRQ136.37817.745+118.633
TTM136.37818.883+117.495
YOY67.00922.272+44.737
5Y398.66820.830+377.838
10Y279.03025.069+253.961
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Chimin Pharm Co Ltd:

  • The EOD is 351.558. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 550.292. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 550.292. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD351.558MRQ550.292-198.734
MRQ550.292TTM550.2920.000
TTM550.292YOY-1,362.812+1,913.104
TTM550.2925Y-847.695+1,397.987
5Y-847.69510Y-579.041-268.654
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD351.55810.196+341.362
MRQ550.29210.068+540.224
TTM550.2921.502+548.790
YOY-1,362.8123.822-1,366.634
5Y-847.6957.817-855.512
10Y-579.0410.759-579.800
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Chimin is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 2.65 means the investor is paying ¥2.65 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Chimin Pharm Co Ltd:

  • The EOD is 1.692. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.649. Based on the equity, the company is underpriced. +1
  • The TTM is 2.649. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.692MRQ2.649-0.957
MRQ2.649TTM2.6490.000
TTM2.649YOY7.192-4.542
TTM2.6495Y10.259-7.610
5Y10.25910Y9.993+0.266
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD1.6922.427-0.735
MRQ2.6492.782-0.133
TTM2.6492.828-0.179
YOY7.1923.290+3.902
5Y10.2593.530+6.729
10Y9.9934.227+5.766
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Chimin Pharm Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7440.7440%0.611+22%0.315+136%0.250+198%
Book Value Per Share--3.3033.3030%2.559+29%2.351+41%1.812+82%
Current Ratio--1.7921.7920%1.122+60%1.136+58%1.816-1%
Debt To Asset Ratio--0.3460.3460%0.433-20%0.463-25%0.357-3%
Debt To Equity Ratio--0.5500.5500%0.848-35%1.066-48%0.731-25%
Dividend Per Share--0.1120.1120%0.071+58%0.095+18%0.070+59%
Eps--0.0640.0640%0.275-77%0.108-40%0.107-40%
Free Cash Flow Per Share--0.0160.0160%-0.014+185%-0.044+377%-0.059+468%
Free Cash Flow To Equity Per Share--0.6290.6290%0.014+4490%0.207+204%0.169+271%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--4.619--------
Intrinsic Value_10Y_min---1.320--------
Intrinsic Value_1Y_max--0.100--------
Intrinsic Value_1Y_min---0.078--------
Intrinsic Value_3Y_max--0.577--------
Intrinsic Value_3Y_min---0.283--------
Intrinsic Value_5Y_max--1.387--------
Intrinsic Value_5Y_min---0.539--------
Market Cap3003154785.280-57%4700823680.0004700823680.0000%9885214376.499-52%11738639019.940-60%9744952542.628-52%
Net Profit Margin--0.0410.0410%0.134-69%0.064-35%0.088-53%
Operating Margin--0.1030.1030%0.190-46%0.125-18%0.106-3%
Operating Ratio--1.4051.4050%1.315+7%1.412-1%1.222+15%
Pb Ratio1.692-57%2.6492.6490%7.192-63%10.259-74%9.993-73%
Pe Ratio87.126-57%136.378136.3780%67.009+104%398.668-66%279.030-51%
Price Per Share5.590-57%8.7508.7500%18.400-52%21.850-60%18.139-52%
Price To Free Cash Flow Ratio351.558-57%550.292550.2920%-1362.812+348%-847.695+254%-579.041+205%
Price To Total Gains Ratio6.530-57%10.22110.2210%26.988-62%135.088-92%118.020-91%
Quick Ratio--0.2470.2470%0.336-27%0.401-38%0.751-67%
Return On Assets--0.0130.0130%0.061-79%0.025-49%0.047-73%
Return On Equity--0.0200.0200%0.119-83%0.053-62%0.076-73%
Total Gains Per Share--0.8560.8560%0.682+26%0.410+109%0.320+167%
Usd Book Value--245225209.706245225209.7060%189965331.213+29%174537064.104+41%134503881.893+82%
Usd Book Value Change Per Share--0.1030.1030%0.084+22%0.044+136%0.035+198%
Usd Book Value Per Share--0.4560.4560%0.354+29%0.325+41%0.250+82%
Usd Dividend Per Share--0.0150.0150%0.010+58%0.013+18%0.010+59%
Usd Eps--0.0090.0090%0.038-77%0.015-40%0.015-40%
Usd Free Cash Flow--1180562.1691180562.1690%-1002439.242+185%-3273115.135+377%-4348370.052+468%
Usd Free Cash Flow Per Share--0.0020.0020%-0.002+185%-0.006+377%-0.008+468%
Usd Free Cash Flow To Equity Per Share--0.0870.0870%0.002+4490%0.029+204%0.023+271%
Usd Market Cap415035991.326-57%649653832.576649653832.5760%1366136626.832-52%1622279912.556-60%1346752441.391-52%
Usd Price Per Share0.773-57%1.2091.2090%2.543-52%3.020-60%2.507-52%
Usd Profit--4763618.1564763618.1560%20387449.691-77%8005900.802-40%7932755.456-40%
Usd Revenue--115706042.977115706042.9770%151808537.294-24%118367110.395-2%94410168.130+23%
Usd Total Gains Per Share--0.1180.1180%0.094+26%0.057+109%0.044+167%
 EOD+4 -4MRQTTM+0 -0YOY+19 -165Y+21 -1410Y+20 -15

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Chimin Pharm Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1587.126
Price to Book Ratio (EOD)Between0-11.692
Net Profit Margin (MRQ)Greater than00.041
Operating Margin (MRQ)Greater than00.103
Quick Ratio (MRQ)Greater than10.247
Current Ratio (MRQ)Greater than11.792
Debt to Asset Ratio (MRQ)Less than10.346
Debt to Equity Ratio (MRQ)Less than10.550
Return on Equity (MRQ)Greater than0.150.020
Return on Assets (MRQ)Greater than0.050.013
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Chimin Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.068
Ma 20Greater thanMa 506.304
Ma 50Greater thanMa 1006.174
Ma 100Greater thanMa 2007.176
OpenGreater thanClose5.660
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,714,060
Total Liabilities939,638
Total Stockholder Equity1,706,950
 As reported
Total Liabilities 939,638
Total Stockholder Equity+ 1,706,950
Total Assets = 2,714,060

Assets

Total Assets2,714,060
Total Current Assets1,046,445
Long-term Assets1,667,616
Total Current Assets
Cash And Cash Equivalents 649,306
Net Receivables 144,297
Inventory 118,093
Other Current Assets 13,166
Total Current Assets  (as reported)1,046,445
Total Current Assets  (calculated)924,863
+/- 121,582
Long-term Assets
Property Plant Equipment 1,348,605
Goodwill 57,478
Intangible Assets 218,942
Other Assets 42,495
Long-term Assets  (as reported)1,667,616
Long-term Assets  (calculated)1,667,519
+/- 96

Liabilities & Shareholders' Equity

Total Current Liabilities584,083
Long-term Liabilities355,555
Total Stockholder Equity1,706,950
Total Current Liabilities
Short Long Term Debt 223,140
Accounts payable 189,258
Other Current Liabilities 86,169
Total Current Liabilities  (as reported)584,083
Total Current Liabilities  (calculated)498,567
+/- 85,516
Long-term Liabilities
Long term Debt 319,426
Capital Lease Obligations Min Short Term Debt10,425
Other Liabilities 23,147
Deferred Long Term Liability 8,425
Long-term Liabilities  (as reported)355,555
Long-term Liabilities  (calculated)361,422
+/- 5,867
Total Stockholder Equity
Common Stock537,237
Retained Earnings 492,768
Total Stockholder Equity (as reported)1,706,950
Total Stockholder Equity (calculated)1,030,006
+/- 676,944
Other
Capital Stock537,237
Common Stock Shares Outstanding 477,041
Net Invested Capital 2,249,515
Net Tangible Assets 1,430,530
Net Working Capital 462,362
Property Plant and Equipment Gross 1,348,605



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
655,298
690,630
713,376
630,040
844,014
922,425
1,574,910
2,124,839
2,084,490
2,291,975
2,425,062
2,714,060
2,714,0602,425,0622,291,9752,084,4902,124,8391,574,910922,425844,014630,040713,376690,630655,298
   > Total Current Assets 
0
0
0
0
494,950
488,853
470,315
597,634
694,991
821,745
829,049
1,046,445
1,046,445829,049821,745694,991597,634470,315488,853494,9500000
       Cash And Cash Equivalents 
30,462
105,755
125,788
118,924
260,311
240,893
179,571
139,399
149,418
242,946
278,516
649,306
649,306278,516242,946149,418139,399179,571240,893260,311118,924125,788105,75530,462
       Short-term Investments 
0
0
0
0
0
0
0
129,468
134,412
128,588
77,680
0
077,680128,588134,412129,4680000000
       Net Receivables 
252,617
200,590
209,051
154,438
142,280
147,365
173,707
198,194
267,828
198,586
170,776
144,297
144,297170,776198,586267,828198,194173,707147,365142,280154,438209,051200,590252,617
       Other Current Assets 
4,347
18,640
10,841
10,075
7,205
10,450
14,448
36,897
37,893
40,564
39,683
13,166
13,16639,68340,56437,89336,89714,44810,4507,20510,07510,84118,6404,347
   > Long-term Assets 
0
0
0
0
0
433,572
1,104,596
1,527,204
1,389,499
1,470,230
1,596,013
1,667,616
1,667,6161,596,0131,470,2301,389,4991,527,2041,104,596433,57200000
       Property Plant Equipment 
166,187
173,241
178,790
166,436
194,855
244,072
689,294
1,056,509
1,030,414
1,104,371
1,214,295
1,348,605
1,348,6051,214,2951,104,3711,030,4141,056,509689,294244,072194,855166,436178,790173,241166,187
       Goodwill 
0
0
0
0
0
0
151,478
172,762
109,864
86,759
67,554
57,478
57,47867,55486,759109,864172,762151,478000000
       Long Term Investments 
0
0
0
0
0
0
10,521
0
0
0
0
0
0000010,521000000
       Intangible Assets 
96,897
94,699
92,265
90,685
88,623
166,503
224,251
255,258
216,531
222,302
217,328
218,942
218,942217,328222,302216,531255,258224,251166,50388,62390,68592,26594,69996,897
       Long-term Assets Other 
0
0
0
0
0
17,945
19,289
27,578
15,513
27,296
17,716
11,977
11,97717,71627,29615,51327,57819,28917,94500000
> Total Liabilities 
272,258
258,101
225,241
188,491
93,023
113,486
646,627
1,078,246
1,011,683
1,245,711
1,050,494
939,638
939,6381,050,4941,245,7111,011,6831,078,246646,627113,48693,023188,491225,241258,101272,258
   > Total Current Liabilities 
225,373
243,012
222,943
187,915
80,121
91,642
484,033
685,786
655,016
986,690
738,904
584,083
584,083738,904986,690655,016685,786484,03391,64280,121187,915222,943243,012225,373
       Short-term Debt 
0
0
0
0
0
944
162,000
270,000
0
0
0
0
0000270,000162,00094400000
       Short Long Term Debt 
0
0
0
0
0
944
162,000
270,000
272,421
389,113
340,279
223,140
223,140340,279389,113272,421270,000162,00094400000
       Accounts payable 
0
45,613
48,186
30,880
48,843
54,254
189,714
254,510
193,377
241,040
215,716
189,258
189,258215,716241,040193,377254,510189,71454,25448,84330,88048,18645,6130
       Other Current Liabilities 
43,373
40,399
49,757
32,034
14,674
17,880
47,998
39,898
44,051
297,521
83,760
86,169
86,16983,760297,52144,05139,89847,99817,88014,67432,03449,75740,39943,373
   > Long-term Liabilities 
0
0
0
0
0
21,844
162,594
392,460
356,667
259,021
311,590
355,555
355,555311,590259,021356,667392,460162,59421,84400000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
-944
-162,000
-270,000
0
4,165
714
10,425
10,4257144,1650-270,000-162,000-94400000
       Long-term Liabilities Other 
0
0
0
0
0
1,256
139,326
367,707
333,601
15,975
0
0
0015,975333,601367,707139,3261,25600000
       Deferred Long Term Liability 
0
0
0
0
3,123
2,040
3,001
2,814
4,670
6,380
10,544
8,425
8,42510,5446,3804,6702,8143,0012,0403,1230000
> Total Stockholder Equity
383,041
432,529
488,135
441,549
721,027
751,242
793,445
809,722
872,086
864,745
1,238,436
1,706,950
1,706,9501,238,436864,745872,086809,722793,445751,242721,027441,549488,135432,529383,041
   Common Stock
120,000
120,000
120,000
120,000
160,000
320,000
320,000
320,000
320,000
320,000
340,743
537,237
537,237340,743320,000320,000320,000320,000320,000160,000120,000120,000120,000120,000
   Retained Earnings Total Equity000000000000
   Accumulated Other Comprehensive Income 000000000000
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
0
0
0
0
0
-280
1,839
2,053
1,938
3,561
-4,374
-2,047
-2,047-4,3743,5611,9382,0531,839-28000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue875,005
Cost of Revenue-492,588
Gross Profit382,417382,417
 
Operating Income (+$)
Gross Profit382,417
Operating Expense-776,645
Operating Income98,361-394,227
 
Operating Expense (+$)
Research Development25,967
Selling General Administrative198,895
Selling And Marketing Expenses-
Operating Expense776,645224,862
 
Net Interest Income (+$)
Interest Income1,277
Interest Expense-22,075
Other Finance Cost-6,213
Net Interest Income-27,011
 
Pretax Income (+$)
Operating Income98,361
Net Interest Income-27,011
Other Non-Operating Income Expenses-
Income Before Tax (EBT)18,41198,361
EBIT - interestExpense = -22,075
-2,111
19,964
Interest Expense22,075
Earnings Before Interest and Taxes (EBIT)-40,485
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax18,411
Tax Provision-3,168
Net Income From Continuing Ops15,24315,243
Net Income-2,111
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-27,011
 

Technical Analysis of Chimin
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Chimin. The general trend of Chimin is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Chimin's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Chimin Pharm Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.85 < 6.02 < 6.24.

The bearish price targets are: 4.7.

Tweet this
Zhejiang Chimin Pharm Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Chimin Pharm Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Chimin Pharm Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Chimin Pharm Co Ltd. The current macd is -0.19319444.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Chimin price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Chimin. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Chimin price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Zhejiang Chimin Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Chimin Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Chimin Pharm Co Ltd. The current adx is 19.63.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Chimin shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Zhejiang Chimin Pharm Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Chimin Pharm Co Ltd. The current sar is 6.23464756.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Zhejiang Chimin Pharm Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Chimin Pharm Co Ltd. The current rsi is 36.07. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Zhejiang Chimin Pharm Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Chimin Pharm Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Chimin Pharm Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Chimin price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Zhejiang Chimin Pharm Co Ltd Daily Stochastic Oscillator ChartZhejiang Chimin Pharm Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Chimin Pharm Co Ltd. The current cci is -175.46919116.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Zhejiang Chimin Pharm Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Chimin Pharm Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Chimin Pharm Co Ltd. The current cmo is -33.98627037.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Zhejiang Chimin Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Chimin Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Chimin Pharm Co Ltd. The current willr is -81.34328358.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Zhejiang Chimin Pharm Co Ltd Daily Williams %R ChartZhejiang Chimin Pharm Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Chimin Pharm Co Ltd.

Zhejiang Chimin Pharm Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Chimin Pharm Co Ltd. The current atr is 0.25254824.

Zhejiang Chimin Pharm Co Ltd Daily Average True Range (ATR) ChartZhejiang Chimin Pharm Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Chimin Pharm Co Ltd. The current obv is 299,283,525.

Zhejiang Chimin Pharm Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Chimin Pharm Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Chimin Pharm Co Ltd. The current mfi is 43.72.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Zhejiang Chimin Pharm Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Chimin Pharm Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Chimin Pharm Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Zhejiang Chimin Pharm Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Chimin Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.068
Ma 20Greater thanMa 506.304
Ma 50Greater thanMa 1006.174
Ma 100Greater thanMa 2007.176
OpenGreater thanClose5.660
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Chimin with someone you think should read this too:
  • Are you bullish or bearish on Chimin? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Chimin? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Chimin Pharm Co Ltd

I send you an email if I find something interesting about Zhejiang Chimin Pharm Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Chimin Pharm Co Ltd.

Receive notifications about Zhejiang Chimin Pharm Co Ltd in your mailbox!